Anebulo Pharmaceuticals Inc (ANEB) ニュース

Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Recent Updates

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from...

Form 8-K - Current report

Form 8-K - Current report

Anebulo Pharmaceuticals to Present at Upcoming Investor and Scientific Conferences

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from...

Anebulo Receives Positive Feedback from FDA on Path to Advance Phase 3 Clinical Development of ANEB-001 and Completes Dosing of Phase 2 Extension

FDA provides favorable input on studies to support ANEB-001 approval Part C Extension of Phase 2 trial completed exploring THC challenge dose of...

Quarterly Report (10-q)

0001815974 false --06-30 Q3

Current Report Filing (8-k)

0001815974 false 0001815974 2023-05-11 2023-05-11 iso4217:USD xbrli:shares...

Anebulo Pharmaceuticals Reports Third Quarter Fiscal 2023 Financial Results and Recent Updates

Anebulo Pharmaceuticals Reports Third Quarter Fiscal 2023 Financial Results and Recent Updates PR...

Initial Statement of Beneficial Ownership (3)

FORM 3          UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...

Current Report Filing (8-k)

Anebulo Pharmaceuticals, Inc. false 0001815974 0001815974 2023-03-28 2023-03-28     UNITED STATES SECURITIES AND EXCHANGE COMMISSION...

Anebulo Pharmaceuticals Announces Positive Complete Phase 2 Clinical Data Demonstrating Potential of ANEB-001 as a Treatment for Acute Cannabinoid Intoxication

Anebulo Pharmaceuticals Announces Positive Complete Phase 2 Clinical Data Demonstrating Potential of ANEB-001...

Current Report Filing (8-k)

0001815974 false 0001815974 2023-03-02 2023-03-02 iso4217:USD xbrli:shares...

Anebulo Pharmaceuticals Expands its Integrated and Outsourced Solutions

Anebulo Pharmaceuticals Expands its Integrated and Outsourced Solutions PR Newswire AUSTIN, Texas, March 8...

 Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2023 Financial Results and Recent Updates

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from...

Quarterly Report (10-q)

0001815974 false Q2 --06-30 2023